Related Experiment Video
Updated: Jun 11, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms
Xiaobao Qi1, Chuncai Zhou, Peng Li
1School of Chemical and Biomedical Engineering, Nanyang Technological University, 62 Nanyang Drive, 637459 Singapore, Singapore.
Abstract:
Short antimicrobial peptides with nine and eleven residues were developed against several clinically important bacterial and fungal pathogens (specifically Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Candida albicans, and Fusarium solani). Twelve analogues of previously reported peptides BP76 (KKLFKKILKFL) and Pac-525 (KWRRWVRWI) were designed, synthesized, and tested for their antimicrobial activities. Two of our eleven amino acid peptides, P11-5 (GKLFKKILKIL) and P11-6 (KKLIKKILKIL), have very low MICs of 3.1-12.5microg ml(-1) against all five pathogens. The MICs of these two peptides against S. aureus, C. albicans and F. solani are four to ten times lower than the corresponding MICs of the reference peptide BP76. P9-4 (KWRRWIRWL), our newly designed nine-amino acid analogue, also has particularly low MICs of 3.1-6.2microg ml(-1) against four of the tested pathogens; these MICs are two to eight times lower than those reported for Pac-525 (6.2-50microg ml(-1)).These new peptides (P11-5, P11-6 and P9-4) also exhibit improved stability in the presence of salts, and have low cytotoxicity as shown by the hemolysis and MTT assays. From the results of field-emission scanning electron microscopy, membrane depolarization and dye-leakage assays, we propose that these peptides exert their action by disrupting membrane lipids. Molecular dynamics simulation studies confirm that P11-6 peptide maintains relatively stable helical structure and exerts more perturbation action on the order of acyl tail of lipid bilayer.
Insights
New short antimicrobial peptides show potent activity against bacterial and fungal pathogens. These novel peptides exhibit enhanced stability and low cytotoxicity, offering a promising therapeutic avenue.
Area of Science:
- Biochemistry
- Microbiology
- Medicinal Chemistry
Background:
- Antimicrobial peptides (AMPs) are crucial in innate immunity and are explored as alternatives to conventional antibiotics.
- Developing short, stable, and potent AMPs against multidrug-resistant pathogens remains a significant challenge.
Purpose of the Study:
- To design, synthesize, and evaluate novel short antimicrobial peptides with enhanced activity and stability.
- To investigate the mechanism of action of the most promising peptide candidates.
Main Methods:
- Peptide design and synthesis of eleven and nine amino acid analogues.
- Antimicrobial activity testing using minimum inhibitory concentration (MIC) assays.
- Cytotoxicity assessment via hemolysis and MTT assays.
- Mechanism of action studies including electron microscopy, membrane depolarization, and dye leakage assays.
- Molecular dynamics simulations.
Main Results:
- Two eleven-amino acid peptides, P11-5 and P11-6, demonstrated low MICs (3.1–12.5 µg/mL) against *Escherichia coli*, *Pseudomonas aeruginosa*, *Staphylococcus aureus*, *Candida albicans*, and *Fusarium solani*.
- A nine-amino acid peptide, P9-4, exhibited low MICs (3.1–6.2 µg/mL) against four of the tested pathogens.
- These novel peptides displayed improved salt stability and low cytotoxicity.
- Mechanism studies suggested membrane lipid disruption as the mode of action, supported by molecular dynamics simulations showing P11-6's interaction with lipid bilayers.
Conclusions:
- Novel short antimicrobial peptides P11-5, P11-6, and P9-4 show significant potential as therapeutic agents against key bacterial and fungal pathogens.
- The peptides exhibit favorable stability and safety profiles, warranting further investigation.
- Their membrane-disrupting mechanism offers a promising strategy against resistant microbes.
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Gram-positive Cell Wall Synthesis
Antifungal Agents
Antimicrobial Effectiveness
Gene Regulation in Microbial Communities: Quorum Sensing
Inhibitors of Bacterial Protein Synthesis

